{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:25:56Z","timestamp":1790796356378,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012621","name":"NIHR University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bpobgyn.2024.102542","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T02:43:05Z","timestamp":1726022585000},"page":"102542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Fetal therapies \u2013 (Stem cell transplantation; enzyme replacement therapy; in utero genetic therapies)"],"prefix":"10.1016","volume":"97","author":[{"given":"Rachel","family":"Sagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102542_bib1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bpobgyn.2024.102542_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tracli.2017.06.006","article-title":"What compatibility in 2017 for the haematopoietic stem cell transplantation?","volume":"24","author":"Lafarge","year":"2017","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Review clinical trials with mesenchymal stem cells: an update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal stem cells current clinical applications: a systematic review","volume":"52","author":"Rodr\u00edguez-Fuentes","year":"2021","journal-title":"Arch Med Res"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102542_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. Beltrami ap","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102542_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-023-01022-z","article-title":"Current perspectives on mesenchymal stromal cell therapy for graft versus host disease","volume":"20","author":"Kadri","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"21","key":"10.1016\/j.bpobgyn.2024.102542_bib8","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib9","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Gene therapy 2017: progress and future directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin Transl Sci."},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102542_bib10","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/stem.3039","article-title":"In utero transplantation of expanded autologous amniotic fluid stem cells results in long-term hematopoietic engraftment","volume":"37","author":"Loukogeorgakis","year":"2019","journal-title":"Stem Cell"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.transproceed.2006.12.019","article-title":"Stem cell transplantation: the lung barrier","volume":"39","author":"Schrepfer","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/104303403321208952","article-title":"Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the \u03b2 -galactosidase and human factor IX genes to early gestation fetal sheep in utero","volume":"14","author":"David","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.gt.3302130","article-title":"Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero","volume":"11","author":"Peebles","year":"2004","journal-title":"Gene Ther"},{"issue":"7","key":"10.1016\/j.bpobgyn.2024.102542_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/hum.2006.17.767","article-title":"Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: toward prenatal prevention of early-onset intestinal diseases","volume":"17","author":"David","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"3 Pt 2","key":"10.1016\/j.bpobgyn.2024.102542_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ajog.2005.06.077","article-title":"Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy","volume":"193","author":"Weisz","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102542_bib16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-018-0106-7","article-title":"Fetal gene therapy for neurodegenerative disease of infants","volume":"24","author":"Massaro","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib17","doi-asserted-by":"crossref","first-page":"1870 LP","DOI":"10.1182\/blood.V99.5.1870","article-title":"Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bpobgyn.2007.07.007","article-title":"Fetal stem-cell transplantation","volume":"22","author":"Tiblad","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bpobgyn.2012.06.005","article-title":"The case for intrauterine stem cell transplantation","volume":"26","author":"Mattar","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2024.102542_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/pd.2527","article-title":"Fetal therapy: 2020 and beyond","volume":"30","author":"Choolani","year":"2010","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.siny.2009.05.005","article-title":"Stem cell and genetic therapies for the fetus","volume":"15","author":"Roybal","year":"2010","journal-title":"Semin Fetal Neonatal Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40291-020-00445-y","article-title":"The future of in utero gene therapy","volume":"24","author":"Peranteau","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102542_bib23","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41431-019-0387-4","article-title":"Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta","volume":"27","author":"Hill","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.bpobgyn.2024.102542_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.4583","article-title":"Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach","volume":"35","author":"Chitty","year":"2015","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib25","first-page":"43","article-title":"EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction","volume":"17","author":"Spencer","year":"2017"},{"issue":"18","key":"10.1016\/j.bpobgyn.2024.102542_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169199","article-title":"Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction","volume":"133","author":"Spencer","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0140-6736(89)92819-5","article-title":"IN-UTERO transplantation of stem cells in bare lymphocyte syndrome","volume":"333","author":"Touraine","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000077957","article-title":"Reappraisal of in utero stem cell transplantation based on long-term results","volume":"19","author":"Touraine","year":"2004","journal-title":"Fetal Diagn Ther"},{"issue":"24","key":"10.1016\/j.bpobgyn.2024.102542_bib29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM199612123352404","article-title":"Treatment of X-linked severe combined immunodeficiency BY IN utero transplantation of paternal bone marrow","volume":"335","author":"Flake","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib30","first-page":"450","article-title":"Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output","volume":"89","author":"Pirovano","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib31","series-title":"In utero stem cell therapy. Journal of reproductive medicine for the obstetrician and gynecologist jun","first-page":"515","author":"Diukman","year":"1992"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1067\/mob.2002.123602","article-title":"Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency","volume":"187","author":"Westgren","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"9040","key":"10.1016\/j.bpobgyn.2024.102542_bib33","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(96)09392-0","article-title":"In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1)","volume":"348","author":"Wengler","year":"1996","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.bpobgyn.2024.102542_bib34","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102542_bib35","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5966\/sctm.2013-0090","article-title":"Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience","volume":"3","author":"G\u00f6therstr\u00f6m","year":"2014","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jimd.12659","article-title":"Fetal gene therapy","volume":"47","author":"Waddington","year":"2024","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib39","doi-asserted-by":"crossref","first-page":"636","DOI":"10.5966\/sctm.2013-0206","article-title":"Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases","volume":"3","author":"Williams","year":"2014","journal-title":"Stem Cells Transl Med"},{"issue":"25","key":"10.1016\/j.bpobgyn.2024.102542_bib40","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102542_bib41","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1182\/blood-2004-02-0627","article-title":"Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy","volume":"104","author":"Waddington","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102542_bib42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/sj.mt.6300219","article-title":"Persistent expression of hF.IX after tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice","volume":"15","author":"Sabatino","year":"2007","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/104303403321208952","article-title":"Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the beta-galactosidase and human factor IX genes to early gestation fetal sheep in utero","volume":"14","author":"David","year":"2003","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/hum.2010.007","article-title":"Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep","volume":"22","author":"David","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102542_bib45","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2011.107","article-title":"Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in macaques","volume":"19","author":"Mattar","year":"2011","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102542_bib46","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.ymthe.2017.04.003","article-title":"In utero transfer of adeno-associated viral vectors produces long-term factor IX levels in a cynomolgus macaque model","volume":"25","author":"Mattar","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib47","series-title":"AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage","author":"Binny","year":"2012"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib48","first-page":"381","article-title":"Noninvasive prenatal diagnosis of hypohidrotic ectodermal dysplasia by tooth germ sonography","volume":"36","author":"W\u00fcnsche","year":"2015","journal-title":"Ultraschall der Med"},{"issue":"17","key":"10.1016\/j.bpobgyn.2024.102542_bib49","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJMoa1714322","article-title":"Prenatal correction of X-linked hypohidrotic ectodermal dysplasia","volume":"378","author":"Schneider","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102542_bib50","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.3390\/ijms24087155","article-title":"A causal treatment for X-linked hypohidrotic ectodermal dysplasia: long-term results of short-term perinatal ectodysplasin A1 replacement","volume":"24","author":"Schneider","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"532","key":"10.1016\/j.bpobgyn.2024.102542_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8980","article-title":"Tolerance induction and microglial engraftment after fetal therapy without conditioning in mice with mucopolysaccharidosis type VII","volume":"12","author":"Nguyen","year":"2020","journal-title":"Sci Transl Med"},{"issue":"23","key":"10.1016\/j.bpobgyn.2024.102542_bib52","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2200587","article-title":"In utero enzyme-replacement therapy for infantile-onset pompe's disease","volume":"387","author":"Cohen","year":"2022","journal-title":"N Engl J Med"},{"issue":"Supplement 1","key":"10.1016\/j.bpobgyn.2024.102542_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2020-142698","article-title":"Utero stem cell transplantation in patients with alpha thalassemia major: interim results of a phase 1 clinical trial","volume":"136","author":"MacKenzie","year":"2020","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bpobgyn.2024.102542_bib54","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/pd.4966","article-title":"Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature","volume":"36","author":"Kreger","year":"2016","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102542_bib55","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164","author":"Van Dijk","year":"2014","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmg.2009.10.007","article-title":"Classification of osteogenesis imperfecta revisited","volume":"53","author":"Van Dijk","year":"2010","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-016-0299-y","article-title":"Advances in the classification and treatment of osteogenesis imperfecta","volume":"14","author":"Thomas","year":"2016","journal-title":"Curr Osteoporos Rep"},{"issue":"14","key":"10.1016\/j.bpobgyn.2024.102542_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102542_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005088.pub3","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"7","author":"Dwan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib61","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2410","article-title":"Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials","volume":"30","author":"Hald","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5966\/sctm.2013-0090","article-title":"Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience","volume":"3","author":"Gotherstrom","year":"2014","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"10.1016\/j.bpobgyn.2024.102542_bib63","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/humu.9430","article-title":"Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV","volume":"27","author":"Pollitt","year":"2006","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib64","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4514","article-title":"What if the prenatal diagnosis of a lethal anomaly turns out to Be wrong?","volume":"137","author":"Kidszun","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib65","volume":"14","author":"Sagar","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib66","first-page":"1","article-title":"Maternal gene delivery for the prevention and treatment of obstetric conditions","author":"D'Alessandro","year":"2024","journal-title":"Curr Stem Cell Reports"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102542_bib67","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/CIRCULATIONAHA.111.034793","article-title":"Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia","volume":"124","author":"Thadhani","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","author":"Turanov","year":"2018","journal-title":"Nat Biotechnol"},{"issue":"19","key":"10.1016\/j.bpobgyn.2024.102542_bib69","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/gt.2008.102","article-title":"Local delivery of VEGF adenovirus to the uterine artery increases vasorelaxation and uterine blood flow in the pregnant sheep","volume":"15","author":"David","year":"2008","journal-title":"Gene Ther"},{"issue":"6","key":"10.1016\/j.bpobgyn.2024.102542_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100021","article-title":"Local over-expression of VEGF-d\u03b4n\u03b4c in the uterine arteries of pregnant sheep results in long-term changes in uterine artery contractility and angiogenesis","volume":"9","author":"Mehta","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102542_bib71","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/gt.2011.158","article-title":"Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A165 in the uterine arteries of pregnant sheep","volume":"19","author":"Mehta","year":"2012","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib72","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/hum.2013.214","article-title":"Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies","volume":"25","author":"Carr","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"12","key":"10.1016\/j.bpobgyn.2024.102542_bib73","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/hum.2016.046","article-title":"Maternal therapy with Ad.VEGF-a165 increases fetal weight at term in a Guinea-pig model of fetal growth restriction","volume":"27","author":"Swanson","year":"2016","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib74","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1152\/ajpregu.00210.2017","article-title":"Perinatal and long-term effects of maternal uterine artery adenoviral VEGF-A165 gene therapy in the growth-restricted Guinea pig fetus","volume":"315","author":"Vaughan","year":"2018","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"10.1016\/j.bpobgyn.2024.102542_bib75","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/1471-0528.15590","article-title":"Achieving orphan designation for placental insufficiency: annual incidence estimations in Europe","volume":"126","author":"Spencer","year":"2019","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib76","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/uog.15880","article-title":"Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction","volume":"47","author":"Sheppard","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2024.102542_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2020.10.012","article-title":"Fetal and maternal safety considerations for in utero therapy clinical trials: iFeTiS consensus statement","volume":"28","author":"Sagar","year":"2020","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2024.102542_bib79","doi-asserted-by":"crossref","first-page":"387.e1","DOI":"10.1016\/j.ajog.2007.10.806","article-title":"Intrahepatic vein for fetal blood sampling: one center's experience","volume":"198","author":"Aina-Mumuney","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/uog.14636","article-title":"Procedure\u2010related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta\u2010analysis","volume":"45","author":"Akolekar","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2024.102542_bib81","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2004.12.087","article-title":"Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series","volume":"193","author":"Somigliana","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2024.102542_bib82","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1701-2163(15)30546-6","article-title":"Prenatal invasive procedures in women with hepatitis B, hepatitis C, and\/or human immunodeficiency virus infections","volume":"36","author":"Gagnon","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"10","key":"10.1016\/j.bpobgyn.2024.102542_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13100","article-title":"Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation","volume":"13","author":"Pilgrim","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib84","series-title":"Amniocentesis and chorionic villus sampling","year":"2010"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib85","series-title":"RCOG consent advice 6: amniocentesis","year":"2006"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib86","series-title":"Prenatal gene therapy","first-page":"371","article-title":"Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application","author":"Coutelle","year":"2012"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib87","doi-asserted-by":"crossref","first-page":"494.e1","DOI":"10.1016\/j.ajog.2019.03.008","article-title":"Subsequent pregnancy outcomes after open maternal-fetal surgery for myelomeningocele","volume":"220","author":"Goodnight","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib88","first-page":"1","article-title":"Development of a neonatal adverse event severity scale through a Delphi consensus approach on behalf of the International Neonatal Consortium","volume":"0","author":"Salaets","year":"2019","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pd.6047","article-title":"Development of standard definitions and grading for maternal and fetal adverse event terminology","volume":"42","author":"Spencer","year":"2022","journal-title":"Prenat Diagn"},{"issue":"8","key":"10.1016\/j.bpobgyn.2024.102542_bib90","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41431-019-0387-4","article-title":"Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta","volume":"27","author":"Hill","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bpobgyn.2024.102542_bib91","article-title":"Paternal consent in prenatal research: ethical aspects","volume":"10","author":"Johansson","year":"2019","journal-title":"Med Heal Care Philos"},{"issue":"Suppl 1","key":"10.1016\/j.bpobgyn.2024.102542_bib92","first-page":"S67","article-title":"Clinical assessment of fetal well-being and fetal safety indicators","volume":"62","author":"David","year":"2022","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2024.102542_bib93","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1089\/bfm.2023.29239.abstracts","article-title":"8 ABM\/EABM European regional conference may 11\u201313, 2023 split, Croatia","volume":"18","author":"Maksym","year":"2023","journal-title":"Breastfeed Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2024.102542_bib94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41582-022-00751-5","article-title":"Prospects for gene replacement therapies in amyotrophic lateral sclerosis","volume":"19","author":"Giovannelli","year":"2023","journal-title":"Nat Rev Neurol"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693424000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693424000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T14:21:14Z","timestamp":1733235674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693424000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":94,"alternative-id":["S1521693424000968"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102542","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fetal therapies \u2013 (Stem cell transplantation; enzyme replacement therapy; in utero genetic therapies)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2024.102542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102542"}}